DK45385A - Hexahydroarylquinolizin og farmaceutisk praeparat indeholdende en saadanforbindelse - Google Patents
Hexahydroarylquinolizin og farmaceutisk praeparat indeholdende en saadanforbindelse Download PDFInfo
- Publication number
- DK45385A DK45385A DK45385A DK45385A DK45385A DK 45385 A DK45385 A DK 45385A DK 45385 A DK45385 A DK 45385A DK 45385 A DK45385 A DK 45385A DK 45385 A DK45385 A DK 45385A
- Authority
- DK
- Denmark
- Prior art keywords
- hexahydroarylquinolizin
- pharmaceutical preparation
- preparation containing
- seed connection
- seed
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
- C07D513/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US57623384A | 1984-02-02 | 1984-02-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
DK45385D0 DK45385D0 (da) | 1985-02-01 |
DK45385A true DK45385A (da) | 1985-09-18 |
Family
ID=24303506
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK45385A DK45385A (da) | 1984-02-02 | 1985-02-01 | Hexahydroarylquinolizin og farmaceutisk praeparat indeholdende en saadanforbindelse |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0154142B1 (de) |
JP (1) | JPS60188385A (de) |
KR (1) | KR900003651B1 (de) |
AT (1) | ATE44529T1 (de) |
AU (1) | AU576550B2 (de) |
CA (1) | CA1240677A (de) |
DE (1) | DE3571438D1 (de) |
DK (1) | DK45385A (de) |
ES (1) | ES8609323A1 (de) |
GR (1) | GR850211B (de) |
IE (1) | IE850253L (de) |
IL (1) | IL74147A (de) |
NZ (1) | NZ210982A (de) |
PT (1) | PT79871B (de) |
ZA (1) | ZA85789B (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4690928A (en) * | 1984-02-02 | 1987-09-01 | Merck & Co., Inc. | Substituted hexahydro arylquinolizines as α2 blockers |
GB8420602D0 (en) * | 1984-08-14 | 1984-09-19 | Wyeth John & Brother Ltd | Thienoquinolizines |
DK127086A (da) * | 1985-03-25 | 1986-09-26 | Schering Corp | Substituerede 1,8-naphthyridoner, fremgangsmaader til deres fremstilling og farmaceutiske kompositioner, der indeholder disse forbindelser |
AU582663B2 (en) * | 1985-08-10 | 1989-04-06 | John Wyeth & Brother Limited | Sulphonamides |
US4686226A (en) * | 1985-09-03 | 1987-08-11 | Merck & Co., Inc. | Substituted benzo[b]furo- and benzo[b]thieno quinolizines |
US4835276A (en) * | 1986-07-03 | 1989-05-30 | Merck & Co., Inc. | Preparation of n-formamidoyl[(s)-1-t-butoxy-3-methyl-2-amino)]1,2,3,4 tetrahydrobenzo [b]furo [2,3-c]pyridine and derivatives |
US4814452A (en) * | 1986-07-03 | 1989-03-21 | Merck & Co., Inc. | Enantioselective synthesis of 1,3,4,6,7,12b(S)-hexahydro-2H-benzo[b]furo[2,3-a]quinolizin-2-one |
NZ221485A (en) * | 1986-08-28 | 1991-04-26 | Merck & Co Inc | Hexahydroarylquinolizine derivatives and pharmaceutical compositions |
US4831035A (en) * | 1986-08-28 | 1989-05-16 | Merck & Co., Inc. | Substituted hexahydroarylquinolizines |
US4956365A (en) * | 1987-04-13 | 1990-09-11 | Syntex (U.S.A.) Inc. | Decahydro-8H-isoquino(2,1-g)(1,6)naphthyridine derivatives and related compounds |
CA1321751C (en) * | 1989-02-21 | 1993-08-31 | Eugene C. Crichlow | Mechanism mediating ruminal stasis in ruminal lactic acidosis |
WO2011067145A1 (en) | 2009-12-04 | 2011-06-09 | Nerviano Medical Sciences S.R.L. | Tricyclopyrazole derivatives |
GB201509006D0 (en) | 2015-05-26 | 2015-07-08 | Redx Pharma Plc | Antibacterial compounds |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1470065C3 (de) * | 1961-06-19 | 1980-07-17 | Merck Patent Gmbh, 6100 Darmstadt | Verfahren zur Herstellung von Chinolizinderivaten |
GB1435573A (en) * | 1973-05-25 | 1976-05-12 | Wyeth John & Brother Ltd | Indoloquinolizines |
US4181657A (en) * | 1978-07-14 | 1980-01-01 | Miles Laboratories, Inc. | 2-Aminooctahydroindolo[2,3-a]quinolizines useful in treating cardiovascular disorders |
GB2106909B (en) * | 1981-10-07 | 1984-09-19 | Wyeth John & Brother Ltd | Benzoquinolizines |
-
1985
- 1985-01-24 GR GR850211A patent/GR850211B/el unknown
- 1985-01-24 IL IL74147A patent/IL74147A/xx unknown
- 1985-01-24 ES ES539799A patent/ES8609323A1/es not_active Expired
- 1985-01-24 PT PT79871A patent/PT79871B/pt unknown
- 1985-01-25 DE DE8585100732T patent/DE3571438D1/de not_active Expired
- 1985-01-25 AT AT85100732T patent/ATE44529T1/de not_active IP Right Cessation
- 1985-01-25 EP EP85100732A patent/EP0154142B1/de not_active Expired
- 1985-01-29 NZ NZ210982A patent/NZ210982A/en unknown
- 1985-01-31 AU AU38220/85A patent/AU576550B2/en not_active Ceased
- 1985-01-31 CA CA000473300A patent/CA1240677A/en not_active Expired
- 1985-02-01 KR KR1019850000635A patent/KR900003651B1/ko active IP Right Grant
- 1985-02-01 IE IE850253A patent/IE850253L/xx unknown
- 1985-02-01 DK DK45385A patent/DK45385A/da not_active Application Discontinuation
- 1985-02-01 ZA ZA85789A patent/ZA85789B/xx unknown
- 1985-02-01 JP JP60016693A patent/JPS60188385A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
IL74147A (en) | 1988-08-31 |
NZ210982A (en) | 1988-04-29 |
GR850211B (de) | 1985-05-24 |
EP0154142A1 (de) | 1985-09-11 |
ATE44529T1 (de) | 1989-07-15 |
IL74147A0 (en) | 1985-04-30 |
KR900003651B1 (ko) | 1990-05-28 |
ZA85789B (en) | 1986-09-24 |
CA1240677A (en) | 1988-08-16 |
ES8609323A1 (es) | 1986-07-16 |
ES539799A0 (es) | 1986-07-16 |
AU3822085A (en) | 1985-08-08 |
DE3571438D1 (en) | 1989-08-17 |
PT79871A (en) | 1985-02-01 |
DK45385D0 (da) | 1985-02-01 |
EP0154142B1 (de) | 1989-07-12 |
AU576550B2 (en) | 1988-09-01 |
IE850253L (en) | 1985-08-02 |
JPS60188385A (ja) | 1985-09-25 |
PT79871B (en) | 1986-12-15 |
KR850005843A (ko) | 1985-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IT8619675A0 (it) | Formulazioni per la preparazione di farmaci a rilascio prolungato adatte alla somministrazione per via orale. | |
DK45385A (da) | Hexahydroarylquinolizin og farmaceutisk praeparat indeholdende en saadanforbindelse | |
DK362189A (da) | Farmaceutisk praeparat til intravenoes indgift | |
ATE71837T1 (de) | Pharmazeutische zusammensetzung mit verzoegerter wirkstoffabgabe. | |
IT8467131A0 (it) | Preparazione farmaceutica a base di n"-ciano-n-4-piridil-n'-1,2,2-trime tilpropilguanidina,particolarmente per il trattamento dell'ipertensione | |
IL65802A (en) | 1-(3-fluoro-2-pyridinyl)piperazine and salts thereof,their preparation and pharmaceutical compositions containing them | |
NO892764D0 (no) | Medikamentell administreringsform for droevtyggere. | |
DK160991C (da) | 5,14-dihydrobenzoe5,6aaisoindolooe2,1-baaisoquinolin-8,13-dionderivater, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende en saadan forbindelse | |
NO873383D0 (no) | Nye farmasoeytisk aktive (benzofurano-2-yl)imidazoler og salter derav, samt fremgangsmaate for deres fremstilling. | |
ES8707729A1 (es) | Un procedimiento para la preparacion de hexahidroarilquinolizinas sustituidas. | |
NO870834L (no) | Glysero-3(2)-fosfo-l-serinderivater og salter derav, fremgangsmaater for fremstilling derav og farmasoeytiske preparater inneholdende derivatene. | |
NO865004L (no) | Nye 16,17-acetalsubstituerte pregnan-21-oinsyrederivater og fremgangsmaate for deres fremstilling. | |
DK447387A (da) | Hexahydroarylquinolizinforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse | |
IT8722647A0 (it) | Composizione farmaceutica per somministrazione nasale. | |
IT8467927A0 (it) | Preparati farmaceutici a base di dobutamina somministrabili per via orale | |
SE8704272D0 (sv) | Pharmaceutisk komposition | |
IT8622783A0 (it) | Derivati imidazolici adattivita' terapeutica, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono. | |
ATE78405T1 (de) | Pharmazeutische zusammensetzung, enthaltend piperidinalkanolderivate. | |
IT8819541A0 (it) | Composizione farmaceutica per somministrazione nasale. | |
IT8822438A0 (it) | Procedimento per la preparazione di ceftriaxone e i suoi sali farmaceuticamente accettabili. | |
NO890328L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 4-amino-2,3-disubstituert-6,7-dihydro-5h-1-pyrindinderivater. | |
IT8619931A0 (it) | Procedimento per la preparazione della 1-(n-metilamidino)-3-(2,6-dimetilfe nil) urea e dei suoi sali farmaceuticamente accettabili. | |
IT8820854A0 (it) | Sali di glicosaminoglicani, procedimento per la loro preparazione e relative composizioni farmaceutiche. | |
IT8821880A0 (it) | Composto terapeuticamente utile, procedimento per la sua preparazione e relative composizioni farmaceutiche. | |
NO902329D0 (no) | Antiinflammatoriske og analgetiske forbindelser, beslektede preparater og fremgangsmaater for fremstilling og anvendelse derav. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AHS | Application shelved for other reasons than non-payment |